Skip to main content
. 2023 Feb 8;12(2):267. doi: 10.3390/biology12020267

Figure 5.

Figure 5

Biomarker during tumor development. Close monitoring of ctDNA allows for the diagnosis as well as early detection of minimal residual disease (MRD) to guide treatment. Adapted with permission from [24,46].